Action initiation shapes mesolimbic dopamine encoding of future rewards
Emilie C J Syed1,2,3, Laura L Grima3, Peter J Magill2
1Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Abstract:
It is widely held that dopamine signaling encodes predictions of future rewards and such predictions are regularly used to drive behavior, but the relationship between these two is poorly defined. We found in rats that nucleus accumbens dopamine following a reward-predicting cue was attenuated unless movement was correctly initiated. Our results indicate that dopamine release in this region is contingent on correct action initiation and not just reward prediction.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
09:13A Fully Automated and Highly Versatile System for Testing Multi-cognitive Functions and Recording Neuronal Activities in Rodents
Published on: May 3, 2012
Related Concept Videos
Timing and Consequences on Behavior
Humans, however, can respond to delayed reinforcers. We often make decisions between immediate small rewards and delayed larger rewards. This ability to delay gratification is a significant...
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Law of Effect
Edward Thorndike's foundational work involved studying learning in animals, particularly using puzzle...
Neurochemical Transmission: Sites of Drug Action
Role of Shaping in Operant Conditioning
The steps involved in shaping begin with reinforcing any response that resembles the desired behavior. For example, parents might praise a child for picking up one toy. As...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
